Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

German Ott

Showing results (331-340 of 374) with videos related to

Pageof 38
Sort By:
Blood|September 29, 2019
Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistryCatalina Amador, Timothy C Greiner, Tayla B Heavican, et al.
Blood|August 13, 2017
Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targetsAlyssa Bouska, Chengfeng Bi, Waseem Lone, et al.
Blood|December 16, 2014
Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphomaJaveed Iqbal, Yulei Shen, Xin Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisoneNathalie A Johnson, Graham W Slack, Kerry J Savage, et al.
Blood|September 6, 2013
Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndromeEkaterina Chigrinova, Andrea Rinaldi, Ivo Kwee, et al.
Blood|July 28, 2005
Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival predictionSilvia Bea, Andreas Zettl, George Wright, et al.
The Lancet. Oncology|August 11, 2015
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registryAlessandro Pastore, Vindi Jurinovic, Robert Kridel, et al.
Nature|December 24, 2010
Oncogenically active MYD88 mutations in human lymphomaVu N Ngo, Ryan M Young, Roland Schmitz, et al.
The New England Journal of Medicine|June 9, 2006
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profilingMichael Hummel, Stefan Bentink, Hilmar Berger, et al.
Genes, Chromosomes & Cancer|April 7, 2025
Subtyping Burkitt Lymphoma by DNA MethylationSelina Glaser, Rabea Wagener, Helene Kretzmer, et al.
Pageof 38

Showing results (331-340 of 374) with videos related to

Sort By:
Pageof 38
Blood|September 29, 2019
Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistryCatalina Amador, Timothy C Greiner, Tayla B Heavican, et al.
Blood|August 13, 2017
Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targetsAlyssa Bouska, Chengfeng Bi, Waseem Lone, et al.
Blood|December 16, 2014
Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphomaJaveed Iqbal, Yulei Shen, Xin Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisoneNathalie A Johnson, Graham W Slack, Kerry J Savage, et al.
Blood|September 6, 2013
Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndromeEkaterina Chigrinova, Andrea Rinaldi, Ivo Kwee, et al.
Blood|July 28, 2005
Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival predictionSilvia Bea, Andreas Zettl, George Wright, et al.
The Lancet. Oncology|August 11, 2015
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registryAlessandro Pastore, Vindi Jurinovic, Robert Kridel, et al.
Nature|December 24, 2010
Oncogenically active MYD88 mutations in human lymphomaVu N Ngo, Ryan M Young, Roland Schmitz, et al.
The New England Journal of Medicine|June 9, 2006
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profilingMichael Hummel, Stefan Bentink, Hilmar Berger, et al.
Genes, Chromosomes & Cancer|April 7, 2025
Subtyping Burkitt Lymphoma by DNA MethylationSelina Glaser, Rabea Wagener, Helene Kretzmer, et al.
Pageof 38